Table 2.
microRNA | B | SE | 95% CI for B | β | 95% CI for β | p-Value | p adj |
---|---|---|---|---|---|---|---|
Mir-1 | 11.810 | 5.35 | 1.089, 22.53 | 0.264 | 0.024, 0.504 | 0.03149 | 0.05353 |
Mir-124a | −3.040 | 5.22 | −13.508, 7.44 | −0.073 | −0.325, 0.179 | 0.56355 | 0.59635 |
Mir-154 | 14.120 | 5.80 | 2.504, 25.74 | 0.355 | 0.063, 0.646 | 0.01813 | 0.04403 |
Mir-21 | 22.630 | 8.31 | 5.96, 39.29 | 0.330 | 0.087, 0.572 | 0.00874 | 0.02533 |
Mir-221 | 20.732 | 7.54 | 5.61, 35.85 | 0.389 | 0.105, 0.672 | 0.00815 | 0.02533 |
Mir-299-5p | 21.906 | 5.97 | 9.934, 33.88 | 0.422 | 0.191, 0.652 | 0.00056 | 0.00476 |
Mir-331-5p | −5.860 | 11.00 | −27.949, 16.23 | −0.080 | −0.381, 0.221 | 0.59635 | 0.59635 |
Mir-375 | −17.890 | 8.04 | −34.003, −1.77 | −0.261 | −0.496, −0.026 | 0.03025 | 0.05353 |
Mir-376a | 10.810 | 4.78 | 1.216, 20.4 | 0.284 | 0.032, 0.536 | 0.02796 | 0.05353 |
Mir-379 | 12.700 | 6.09 | 0.49, 24.91 | 0.295 | 0.011, 0.578 | 0.04178 | 0.05464 |
Mir-382 | 11.750 | 5.45 | 0.757, 22.74 | 0.387 | 0.025, 0.748 | 0.03676 | 0.05464 |
Mir-409-5p | 20.970 | 7.70 | 5.492, 36.44 | 0.366 | 0.096, 0.636 | 0.00894 | 0.02533 |
Mir-423-5p | 40.190 | 8.69 | 22.74, 57.63 | 0.518 | 0.293, 0.743 | 0.00003 | 0.00051 |
Mir-451 | −20.150 | 6.20 | −32.59, −7.71 | −0.414 | −0.669, −0.158 | 0.00203 | 0.01150 |
Mir-499-5p | 5.520 | 9.62 | −13.788, 24.82 | 0.070 | −0.176, 0.316 | 0.56890 | 0.59635 |
Mir-654-5p | 15.130 | 7.17 | 0.759, 29.5 | 0.318 | 0.016, 0.621 | 0.03945 | 0.05464 |
Mir-744 | 6.140 | 7.25 | −8.504, 20.78 | 0.148 | −0.205, 0.501 | 0.40244 | 0.48868 |
Analyses were adjusted for age, sex, personal history of diabetes mellitus, hypertension, hypercholesterolemia, and smoking habit. B = unstandardized regression coefficient; SE = standard error; 95% CI = 95% confidence interval of regression coefficients; β = standardized regression coefficient; padj = Benjamini-Hochberg adjusted p-value.